Stopped: Lack of resources.
The purpose of this single-center, randomized, prospective cohort study is to evaluate the clinical outcome and negative-pressure wound therapy (NPWT) mediated modulation of the biologic milieu of a modified NPWT dressing on split-thickness skin graft (STSG) donor sites.
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Pain as measured by visual analog scale (VAS).
Timeframe: Assessed up to 14 days
Wound healing rate (re-epithelialization)
Timeframe: Assessed up to 1 month
Wound exudate: mRNA expression
Timeframe: Assessed up to 14 days
Wound exudate: protein content
Timeframe: Assessed up to 14 days
Tissue sample: re-epithelialization and granulation percentage
Timeframe: Assessed up to 14 days
Tissue sample: epidermal thickness
Timeframe: Assessed up to 14 days